99 related articles for article (PubMed ID: 4945685)
1. Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):290-5. PubMed ID: 4945685
[No Abstract] [Full Text] [Related]
2. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
3. Anaphylatoxin formation by contact activation of plasma. 3. Fixation of two different anaphylatoxin-forming complexes on zymosan.
Brade V; Schmidt G; Vogt W
Eur J Immunol; 1972 Apr; 2(2):180-6. PubMed ID: 4644242
[No Abstract] [Full Text] [Related]
4. Chemistry and biology of the anaphylatoxin related serum peptide system. I. Purification, crystallization and properties of classical anaphylatoxin from rat serum.
Wissler JH
Eur J Immunol; 1972 Feb; 2(1):73-83. PubMed ID: 5082613
[No Abstract] [Full Text] [Related]
5. Studies on the relation between the fifth component of complement and anaphylatoxinogen.
Vogt W; Lufft E; Schmidt G
Eur J Immunol; 1971 Apr; 1(2):141-5. PubMed ID: 4108378
[No Abstract] [Full Text] [Related]
6. Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation.
Hadding U; Dierich M; König W; Limbert M; Schorlemmer HU; Bitter-Suermann D
Eur J Immunol; 1973 Aug; 3(8):527-9. PubMed ID: 4127819
[No Abstract] [Full Text] [Related]
7. Studies on heart anaphylaxis. V. Cross-desensitisation between antigen, anaphylatoxin, and compound 48-80 in the guinea-pig papillary muscle.
Bernauer W; Hahn F; Nimptsch P; Wissler J
Int Arch Allergy Appl Immunol; 1972; 42(1):136-51. PubMed ID: 5060266
[No Abstract] [Full Text] [Related]
8. Complement fixation by a single molecule of gamma G hemolysin.
Frank MM; Gaither TA
J Immunol; 1970 Jun; 104(6):1458-66. PubMed ID: 4916315
[No Abstract] [Full Text] [Related]
9. Production of antibodies monospecifically reactive with the third component of guinea pig complement.
Burkholder PM
Int Arch Allergy Appl Immunol; 1970; 37(2):124-42. PubMed ID: 5411244
[No Abstract] [Full Text] [Related]
10. Anaphylatoxin tachyphylaxis and anaphylactic histamine release.
Hahn F; Maack T; Müller G; Mitze R; Ebner C
Int Arch Allergy Appl Immunol; 1970; 37(6):596-606. PubMed ID: 4188924
[No Abstract] [Full Text] [Related]
11. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
da Silva WD; Eisele JW; Lepow IH
J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
[TBL] [Abstract][Full Text] [Related]
12. Contraction of the guinea-pig ileum induced by anaphylatoxin independent of histamine release.
Bodammer G; Vogt W
Int Arch Allergy Appl Immunol; 1970; 39(5-6):648-57. PubMed ID: 4099445
[No Abstract] [Full Text] [Related]
13. Anaphylatoxin in its relation to the complement system.
Jensen J
Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
[TBL] [Abstract][Full Text] [Related]
14. Anaphylatoxin release from the third component of human complement by hydroxylamine.
Budzko DB; Müller-Eberhard H
Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
[TBL] [Abstract][Full Text] [Related]
15. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.
WARD PA; COCHRANE CG
J Exp Med; 1965 Feb; 121(2):215-34. PubMed ID: 14264268
[TBL] [Abstract][Full Text] [Related]
16. Passive immune lysis with chromic chloride-treated erythrocytes.
Perucca PJ; Faulk WP; Fudenberg HH
J Immunol; 1969 Apr; 102(4):812-20. PubMed ID: 5768191
[No Abstract] [Full Text] [Related]
17. 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells.
Yamada H; Yamada A; Hollander VP
J Immunol; 1970 Jan; 104(1):251-5. PubMed ID: 4904002
[No Abstract] [Full Text] [Related]
18. Bypass-activation of the complement system starting with C3. II. C3-activation by gamma-1-immune aggregates in guinea pig serum.
König W; Bitter-Suermann D; Dierich M; Hadding U
Immunochemistry; 1973 Jul; 10(7):431-7. PubMed ID: 4125109
[No Abstract] [Full Text] [Related]
19. Antibody production to low molecular drugs in experimental animals and in man.
Juji T; Matsuhashi T
Jpn J Exp Med; 1969 Feb; 39(1):21-34. PubMed ID: 4186688
[No Abstract] [Full Text] [Related]
20. Immunosuppressive effects of antilymphocyte serum in complement-deficient mice: evidence that immune cytolysis is not essential for ALS activity.
Barth RF; Carroll GF
J Immunol; 1970 Feb; 104(2):522-4. PubMed ID: 4904885
[No Abstract] [Full Text] [Related]
[Next] [New Search]
